iBio, Inc. SEC filings IBIO
iBio, Inc. has 909 filings in SEC EDGAR's recent list, going back to Mar 7, 2008. Its latest annual report, Form ARS, was filed on Sep 4, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Apr 29, 2026 | — |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| S-3 | Shelf registration | Feb 27, 2026 | — |
| 424B3 | Prospectus | Feb 9, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Aug 21, 2025 | — |
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| S-3 | Shelf registration | Jun 13, 2025 | — |
| 424B5 | Prospectus supplement | Apr 30, 2025 | — |
| 424B5 | Prospectus supplement | Apr 30, 2025 | — |
| 424B5 | Prospectus supplement | Apr 30, 2025 | — |
| 424B3 | Prospectus | Feb 11, 2025 | — |
| S-8 | Employee stock plan registration | Jan 31, 2025 | — |
| S-3 | Shelf registration | Jan 31, 2025 | — |
| 424B5 | Prospectus supplement | Aug 6, 2024 | — |
| S-3/A | Filing | Jul 25, 2024 | — |
| S-3 | Shelf registration | Jul 3, 2024 | — |
| 424B3 | Prospectus | Apr 25, 2024 | — |
| S-3 | Shelf registration | Apr 16, 2024 | — |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 424B3 | Prospectus | Dec 6, 2023 | — |
| S-1/A | Amended registration statement | Nov 30, 2023 | — |
| S-1 | Registration statement | Oct 27, 2023 | — |
| POS AM | Filing | Sep 29, 2023 | — |
| 424B3 | Prospectus | Aug 14, 2023 | — |
| 424B5 | Prospectus supplement | Aug 7, 2023 | — |
| S-1 | Registration statement | Aug 7, 2023 | — |
| 424B3 | Prospectus | Feb 22, 2023 | — |
| 424B5 | Prospectus supplement | Dec 8, 2022 | — |
| 424B5 | Prospectus supplement | Dec 6, 2022 | — |
| S-8 | Employee stock plan registration | Jan 11, 2021 | — |
| S-8 | Employee stock plan registration | Jan 11, 2021 | — |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 7, 2020 | — |
| S-3 | Shelf registration | Nov 25, 2020 | — |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| 424B5 | Prospectus supplement | Jun 17, 2020 | — |
| 424B5 | Prospectus supplement | May 14, 2020 | — |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| S-3/A | Form s-3/a | Mar 13, 2020 | — |
| S-3 | Shelf registration | Feb 28, 2020 | — |
| 424B4 | Prospectus | Oct 28, 2019 | — |
| S-1/A | Amended registration statement | Oct 24, 2019 | — |
| S-1/A | Amended registration statement | Oct 15, 2019 | — |
| FWP | Free writing prospectus | Oct 11, 2019 | — |
| FWP | Free writing prospectus | Sep 17, 2019 | — |
| S-1 | Registration statement | Aug 28, 2019 | — |
| S-8 | Employee stock plan registration | Jan 15, 2019 | — |
| 424B4 | Prospectus | Jun 22, 2018 | — |
| S-1/A | Amended registration statement | Jun 21, 2018 | — |
| FWP | Free writing prospectus | Jun 13, 2018 | — |
| S-1/A | Amended registration statement | Jun 11, 2018 | — |
| S-1 | Registration statement | May 2, 2018 | — |
| 424B3 | Prospectus | Jan 9, 2018 | — |
| 424B3 | Prospectus | Dec 28, 2017 | — |
| 424B3 | Prospectus | Dec 5, 2017 | — |
| 424B5 | Prospectus supplement | Nov 30, 2017 | — |
| 424B5 | Prospectus supplement | Nov 28, 2017 | — |
| 424B3 | Prospectus | Nov 21, 2017 | — |
| 424B3 | Prospectus | Sep 18, 2017 | — |
| 424B3 | Prospectus | Aug 14, 2017 | — |
| S-1/A | Amended registration statement | Aug 7, 2017 | — |
| S-1 | Registration statement | Aug 4, 2017 | — |
| 424B5 | Prospectus supplement | May 29, 2015 | — |
| 424B3 | Prospectus | Feb 25, 2015 | — |
| 424B3 | Prospectus | Dec 12, 2014 | — |
| S-3 | Shelf registration | Nov 20, 2014 | — |
| 424B3 | Prospectus | Nov 19, 2014 | — |
| 424B3 | Prospectus | Nov 13, 2014 | — |
| 424B3 | Prospectus | Nov 5, 2014 | — |
| 424B3 | Prospectus | Oct 20, 2014 | — |
| S-1 | Registration statement | Oct 6, 2014 | — |
| 424B5 | Prospectus supplement | Oct 16, 2013 | — |
| 424B5 | Prospectus supplement | Apr 23, 2013 | — |
| 424B5 | Prospectus supplement | Apr 23, 2013 | — |
| 424B5 | Prospectus supplement | Apr 22, 2013 | — |
| 424B5 | Prospectus supplement | Feb 1, 2013 | — |
| S-8 | Employee stock plan registration | May 29, 2012 | — |
| 424B5 | Prospectus supplement | Jan 12, 2012 | — |
| 424B5 | Prospectus supplement | Jan 9, 2012 | — |
| S-3/A | Filing | Jul 26, 2011 | — |
| S-3 | Shelf registration | Jul 8, 2011 | — |
| 424B3 | Prospectus | Mar 21, 2011 | — |
| S-3/A | Filing | Mar 14, 2011 | — |
| S-3/A | Filing | Mar 7, 2011 | — |
| S-3/A | Filing | Jan 27, 2011 | — |
| S-1 | Registration statement | Dec 21, 2010 | — |
| S-1 | Registration statement | Jun 7, 2010 | — |
| 424B3 | Prospectus | May 26, 2010 | — |
| 424B3 | Prospectus | Apr 8, 2010 | — |
| 424B3 | Prospectus | Mar 5, 2010 | — |
| 424B3 | Prospectus | Feb 24, 2010 | — |
| 424B3 | Prospectus | Nov 19, 2009 | — |
| 424B3 | Prospectus | Oct 28, 2009 | — |
| S-1 | Registration statement | Oct 9, 2009 | — |
| 424B3 | Prospectus | Aug 18, 2009 | — |
| 424B3 | Prospectus | May 18, 2009 | — |
| 424B3 | Prospectus | May 15, 2009 | — |
| S-1 | Registration statement | Apr 24, 2009 | — |
Showing 101 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBIO (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1420720
- Former names
- iBio, Inc. (until Oct 19, 2026); iBioPharma, Inc. (until Aug 14, 2009); InB:Biotechnologies, Inc. (until Jul 17, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.